STOCK TITAN

Cardiff Lexingto Financials

CDIX
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Cardiff Lexingto (CDIX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 24 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Altman Z-Score Distress
-2.59

Cardiff Lexingto scores -2.59, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($36.6M) relative to total liabilities ($26.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Weak
3/9

Cardiff Lexingto passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.52x

For every $1 of reported earnings, Cardiff Lexingto generates $0.52 in operating cash flow (-$2.9M OCF vs -$5.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
0.2x

Cardiff Lexingto earns $0.2 in operating income for every $1 of interest expense ($1.1M vs $6.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$11.5M
YoY+39.5%
5Y CAGR+27.3%
10Y CAGR+23.6%

Cardiff Lexingto generated $11.5M in revenue in fiscal year 2025. This represents an increase of 39.5% from the prior year.

EBITDA
$1.1M
YoY+714.4%

Cardiff Lexingto's EBITDA was $1.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 714.4% from the prior year.

Net Income
-$5.5M
YoY-66.7%

Cardiff Lexingto reported -$5.5M in net income in fiscal year 2025. This represents a decrease of 66.7% from the prior year.

EPS (Diluted)
$-0.98
YoY+10.1%

Cardiff Lexingto earned $-0.98 per diluted share (EPS) in fiscal year 2025. This represents an increase of 10.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$319K
YoY-73.2%
5Y CAGR+2.7%
10Y CAGR+16.1%

Cardiff Lexingto held $319K in cash against $18.6M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
14M
YoY+168.6%

Cardiff Lexingto had 14M shares outstanding in fiscal year 2025. This represents an increase of 168.6% from the prior year.

Margins & Returns

Gross Margin
62.5%
YoY+8.9pp
5Y CAGR+10.8pp
10Y CAGR+34.3pp

Cardiff Lexingto's gross margin was 62.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 8.9 percentage points from the prior year.

Operating Margin
9.5%
YoY+11.9pp
5Y CAGR+61.8pp
10Y CAGR+290.9pp

Cardiff Lexingto's operating margin was 9.5% in fiscal year 2025, reflecting core business profitability. This is up 11.9 percentage points from the prior year.

Net Margin
-47.7%
YoY-7.8pp
5Y CAGR+34.4pp
10Y CAGR+236.1pp

Cardiff Lexingto's net profit margin was -47.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.8 percentage points from the prior year.

Return on Equity
N/A

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

CDIX Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $2.8M-9.4% $3.1M+9.7% $2.8M-4.3% $2.9M-6.6% $3.1M+130.2% $1.4M-7.9% $1.5M-36.6% $2.3M
Cost of Revenue $1.0M-12.0% $1.1M+5.1% $1.1M+1.7% $1.1M-2.3% $1.1M+9.9% $1.0M+26.2% $793K-16.4% $948K
Gross Profit $1.8M-7.8% $1.9M+12.6% $1.7M-7.9% $1.8M-8.9% $2.0M+469.2% $355K-47.7% $679K-50.6% $1.4M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $1.8M+50.3% $1.2M+24.0% $987K-22.9% $1.3M-11.1% $1.4M+53.8% $937K+12.2% $835K-2.0% $851K
Operating Income -$696K-208.2% $643K+5.5% $610K+12.1% $544K+63.8% $332K+156.8% -$585K-266.9% -$159K-172.8% $219K
Interest Expense $2.2M+26.2% $1.8M-3.8% $1.8M+84.9% $993K-34.3% $1.5M+9.0% $1.4M+3252.2% $41K-61.5% $107K
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$2.7M-134.7% -$1.1M+6.7% -$1.2M-172.1% -$451K+50.5% -$910K+54.0% -$2.0M-1403.2% -$132K+53.5% -$283K
EPS (Diluted) N/A $-0.07+12.5% $-0.08-60.0% $-0.05 N/A $-0.16-300.0% $-0.04+63.6% $-0.11

CDIX Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $29.1M+5.4% $27.6M+4.1% $26.5M+4.7% $25.3M+5.9% $23.9M+1.7% $23.5M-4.8% $24.7M+9.3% $22.6M
Current Assets $22.6M+7.4% $21.0M+5.9% $19.9M+6.8% $18.6M+8.1% $17.2M+2.7% $16.8M-7.3% $18.1M+13.5% $15.9M
Cash & Equivalents $319K+37.3% $232K-58.5% $560K-43.8% $997K-16.1% $1.2M-39.1% $1.9M-39.0% $3.2M+155.0% $1.3M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $22.1M+6.6% $20.7M+7.8% $19.2M+9.7% $17.5M+9.8% $15.9M+7.7% $14.8M-0.4% $14.9M+1.4% $14.6M
Goodwill $5.7M0.0% $5.7M0.0% $5.7M0.0% $5.7M0.0% $5.7M0.0% $5.7M0.0% $5.7M0.0% $5.7M
Total Liabilities $26.0M+15.1% $22.6M+10.0% $20.5M+12.7% $18.2M-14.2% $21.2M+7.4% $19.8M+39.4% $14.2M-33.6% $21.4M
Current Liabilities $25.8M+15.4% $22.4M+10.3% $20.3M+13.4% $17.9M+12.6% $15.9M+8.5% $14.6M+5.4% $13.9M-7.4% $15.0M
Long-Term Debt $18.6M+23.2% $15.1M+15.0% $13.1M+22.5% $10.7M+16.2% $9.2M+12.1% $8.2M+11.5% $7.4M+96.8% $3.7M
Total Equity -$2.5M-577.7% -$364K-148.4% $754K-63.0% $2.0M-24.2% $2.7M-28.0% $3.7M-36.6% $5.9M+386.0% $1.2M
Retained Earnings -$79.5M-3.9% -$76.5M-1.9% -$75.1M-2.0% -$73.6M-1.0% -$72.9M-1.6% -$71.8M-3.2% -$69.6M-0.7% -$69.1M

CDIX Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$390K+32.1% -$574K+58.9% -$1.4M-184.4% -$491K+32.0% -$723K+20.4% -$908K-805.4% -$100K+90.3% -$1.0M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow $476K+93.2% $247K-74.3% $961K+220.2% $300K+872.1% -$39K+88.5% -$339K-116.6% $2.0M+56.0% $1.3M
Dividends Paid $0 $0 $0-100.0% $50K $0 $0-100.0% $100K $0
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

CDIX Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 63.5%+1.1pp 62.4%+1.6pp 60.8%-2.3pp 63.1%-1.6pp 64.8%+38.6pp 26.2%-19.9pp 46.1%-13.1pp 59.2%
Operating Margin -25.1%-46.1pp 21.0%-0.8pp 21.9%+3.2pp 18.7%+8.0pp 10.6%+53.8pp -43.2%-32.3pp -10.8%-20.3pp 9.4%
Net Margin -96.9%-59.5pp -37.4%+6.6pp -44.0%-28.5pp -15.5%+13.7pp -29.2%+116.7pp -145.9%-137.0pp -8.9%+3.3pp -12.2%
Return on Equity N/A N/A -162.7%-140.6pp -22.1%+11.8pp -33.9%+19.1pp -53.0%-50.8pp -2.2%+21.2pp -23.4%
Return on Assets -9.2%-5.1pp -4.1%+0.5pp -4.6%-2.9pp -1.8%+2.0pp -3.8%+4.6pp -8.4%-7.9pp -0.5%+0.7pp -1.3%
Current Ratio 0.87-0.1 0.94-0.0 0.98-0.1 1.04-0.0 1.08-0.1 1.14-0.2 1.30+0.2 1.06
Debt-to-Equity -7.52+33.8 -41.35-58.7 17.39+12.1 5.26+1.8 3.43+1.2 2.20+0.9 1.25-1.8 3.09
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$2.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.87), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Cardiff Lexingto (CDIX) reported $11.5M in total revenue for fiscal year 2025. This represents a 39.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Cardiff Lexingto (CDIX) revenue grew by 39.5% year-over-year, from $8.3M to $11.5M in fiscal year 2025.

No, Cardiff Lexingto (CDIX) reported a net income of -$5.5M in fiscal year 2025, with a net profit margin of -47.7%.

Cardiff Lexingto (CDIX) reported diluted earnings per share of $-0.98 for fiscal year 2025. This represents a 10.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cardiff Lexingto (CDIX) had EBITDA of $1.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Cardiff Lexingto (CDIX) had $319K in cash and equivalents against $18.6M in long-term debt.

Cardiff Lexingto (CDIX) had a gross margin of 62.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Cardiff Lexingto (CDIX) had an operating margin of 9.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cardiff Lexingto (CDIX) had a net profit margin of -47.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Cardiff Lexingto (CDIX) generated -$2.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cardiff Lexingto (CDIX) had $29.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Cardiff Lexingto (CDIX) had 14M shares outstanding as of fiscal year 2025.

Cardiff Lexingto (CDIX) had a current ratio of 0.87 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Cardiff Lexingto (CDIX) had a debt-to-equity ratio of -7.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cardiff Lexingto (CDIX) had a return on assets of -18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Cardiff Lexingto (CDIX) had $319K in cash against an annual operating cash burn of $2.9M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Cardiff Lexingto (CDIX) has negative shareholder equity of -$2.5M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Cardiff Lexingto (CDIX) has an Altman Z-Score of -2.59, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Cardiff Lexingto (CDIX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cardiff Lexingto (CDIX) has an earnings quality ratio of 0.52x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cardiff Lexingto (CDIX) has an interest coverage ratio of 0.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top